Monday, November 25, 2013
Saturday, November 9, 2013
It is unlikely that artificial intelligence (AI) will ever be able to duplicate the workings of the human brain. However as the field of AI evolves, scientists have become less interested in duplicating the mind and more interested in using the mind as a guide towards exploring the filed of intelligence itself.
The exploration, manipulation and expansion of intelligence is a rapidly growing field, where scientists are discovering entirely new channels of intelligence and increased levels of human-like intelligence.
And emerging from all of this, is not just new information of the brain but a scientific field that is morphing from artificial intelligence to a realm of unknown intelligence. And that's exciting.
Wednesday, September 11, 2013
(AI) is any man-made machine that can process information and react to it in
some productive way. John
McCarthy, the brilliant computer and cognitive scientist, who coined the term
in 1955, defined AI as "the science and engineering of making intelligent
There is of course, an increasingly blurred line between purely mechanical AI, and OI, organic intelligence. On one end of the spectrum, there is the computer, robot, cell phone, calculator, microwave and electronics and on the other, there is the human being, animal, plant or organic cell. But between the two spectrums, there is a growing fusion between the two, the development of implanted micro-machines for example, alleviating pain, vascular plaque, pacing the heart, regulating brainwaves, targeting cancer cells; a growing world of borgs, where both intelligences can serve each other, intertwining towards the great unknown.
Wednesday, September 4, 2013
Wednesday, August 14, 2013
It is generally assumed that all cancer cells within a tumor are the same and equally dangerous. That
is not the case. Not only are there genetically different cells within a tumor, but only a small minority of them actually drive tumor growth, making it dangerous to the rest of the body.
As we enter the Genetic Age, scientists and physicians continue to genetically identify cancerous cells and target them with corresponding inhibitor drugs. This tailored approach has made huge strides in fighting cancerous cells. However, more recognition needs to be given to the reality that within each tumor, not all cancer cells are genetically alike--calling for a cocktail approach, as with the HIV treatment. And most critically, only a narrow selection of cancer cells should be targeted within the tumor: those that drive tumor growth. To destroy cancerous cells that do not drive growth, simply facilitates growth-inducing cells to dominate and become increasingly problematic.